Skip to main content
SOLV
NYSE Industrial Applications And Services

Solventum Reports Strong Q1 Adjusted EPS, Raises Full-Year Guidance to High End of Range

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$67.067
Mkt Cap
$11.972B
52W Low
$62.38
52W High
$88.2
52W Position info
7.5% above low
Off High info
24% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

SOLV is trading near its 52-week low of $62.38 (7.5% above the low).

Summary

Solventum reported first-quarter 2026 adjusted diluted EPS of $1.48, a 10.6% increase year-over-year, exceeding expectations, and affirmed full-year organic sales growth while projecting adjusted EPS toward the high end of its guidance range.


Key Events · Earnings and Guidance · SOLV

  • Q1 Adjusted EPS Beat

    Reported adjusted diluted EPS of $1.48, a 10.6% increase year-over-year, surpassing expectations.

  • Full-Year Guidance Raised

    Affirmed full-year 2026 organic sales growth guidance and now expects adjusted EPS to be toward the high end of the existing $6.40 to $6.60 range.

  • Organic Sales Growth

    Achieved 2.1% organic sales growth in Q1 2026, reflecting strong performance across all reportable segments.

  • GAAP and Cash Flow Decline

    GAAP diluted EPS decreased by 91.0% to $0.07, and free cash flow was negative $(273) million, primarily due to separation activities and seasonality.


Analysis · SOLV · Industrial Applications And Services

This 8-K officially releases Solventum's first-quarter 2026 financial results, confirming the positive adjusted earnings per share and organic sales growth previously reported by news outlets. While GAAP diluted EPS saw a significant decline and free cash flow was negative, the company's adjusted performance and upward revision of its full-year adjusted EPS guidance indicate operational strength and confidence in its transformation initiatives. Investors will likely focus on the adjusted metrics and the reaffirmed full-year outlook, which suggests a stable trajectory despite the GAAP and cash flow headwinds attributed to separation activities and seasonality.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SOLV was trading at $67.07 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $12B. The 52-week trading range was $62.38 to $88.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SOLV - Latest Insights

SOLV
Nov 05, 2026, 5:17 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $81.05
Real-time Price: $89.91 info
Change: +$8.86 (+11%) info
Market Cap: $15.385B info
SOLV
Nov 05, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $87.18
Real-time Price: $89.91 info
Change: +$2.73 (+3%) info
Market Cap: $15.385B info
SOLV
Nov 05, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $87.18
Real-time Price: $89.91 info
Change: +$2.73 (+3%) info
Market Cap: $15.385B info
SOLV
Aug 05, 2026, 6:11 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $90.42
Real-time Price: $89.91 info
Change: -$0.5127 (-0.57%) info
Market Cap: $15.385B info
SOLV
Aug 05, 2026, 5:27 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $90.42
Real-time Price: $89.91 info
Change: -$0.5127 (-0.57%) info
Market Cap: $15.385B info